Growth Metrics

NovoCure (NVCR) Asset Utilization Ratio (2016 - 2026)

NovoCure's Asset Utilization Ratio history spans 12 years, with the latest figure at 0.85 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 69.61% to 0.85 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.85, a 69.61% increase, with the full-year FY2025 number at 0.64, up 26.38% from a year prior.
  • Asset Utilization Ratio hit 0.85 in Q1 2026 for NovoCure, up from 0.61 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for NVCR hit a ceiling of 0.85 in Q1 2026 and a floor of 0.44 in Q2 2023.
  • Historically, Asset Utilization Ratio has averaged 0.5 across 5 years, with a median of 0.47 in 2024.
  • Biggest five-year swings in Asset Utilization Ratio: dropped 7.71% in 2023 and later skyrocketed 69.61% in 2026.
  • Tracing NVCR's Asset Utilization Ratio over 5 years: stood at 0.45 in 2022, then fell by 2.27% to 0.44 in 2023, then increased by 10.61% to 0.49 in 2024, then grew by 23.15% to 0.61 in 2025, then surged by 39.96% to 0.85 in 2026.
  • Business Quant data shows Asset Utilization Ratio for NVCR at 0.85 in Q1 2026, 0.61 in Q4 2025, and 0.49 in Q3 2025.